Faes Farma S.A. Logo

Faes Farma S.A.

FAE | MC

Overview

Corporate Details

ISIN(s):
ES0134950F36
LEI:
959800FXZQY7U3P1G969
Country:
Spain
Address:
AVENIDA AUTONOMIA, 10-, 48940 Leioa
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Faes Farma S.A. is an international pharmaceutical company, founded in 1933, that engages in the research, development, manufacturing, and marketing of pharmaceutical products and animal nutrition solutions. The company operates through two primary divisions: Pharma & Healthcare and FARM Faes. The Pharma division provides treatments for common global health issues, including allergic, gastrointestinal, and immune-related conditions, featuring proprietary molecules such as the leading antihistamine Bilastine and Calcifediol for Vitamin D deficiency. The FARM Faes division develops and markets specialized nutritional solutions and supplements for sustainable animal production. With a strong focus on R&D and a direct presence in Europe, Latin America, Africa, and the Middle East, Faes Farma serves both human and animal health markets globally.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Faes Farma S.A.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-16 00:00
Post-Annual General Meeting Information
Acuerdo Junta Extraordinaria de Accionistas
Spanish 115.9 KB
2025-06-25 00:00
Post-Annual General Meeting Information
Aspectos relevantes de la Junta de Accionistas 2025
Spanish 159.0 KB
2025-06-25 00:00
Investor Presentation
Presentación Junta de Accionistas 2025
Spanish 4.2 MB
2025-06-11 00:00
Pre-Annual General Meeting Information
Junta General Extraordinaria de Accionistas
Spanish 167.3 KB
2025-05-19 15:51
Pre-Annual General Meeting Information
Convocatoria de la Junta General de Accionistas de 2025
Spanish 180.2 KB
2025-05-19 00:00
Pre-Annual General Meeting Information
Convocatoria de la Junta General de Accionistas de 2025
Spanish 180.2 KB
2025-05-06 08:25
Investor Presentation
Informe de negocio del primer trimestre de 2025
Spanish 1.7 MB
2025-04-29 16:08
Report Publication Announcement
Faes Farma anuncia la celebración de un webcast para presentar los resultados d…
Spanish 65.2 KB
2025-04-22 11:39
Investor Presentation
Presentación Capital Markets Day 2025
Spanish 4.7 MB
2025-04-22 09:56
Investor Presentation
La Sociedad comunica que hoy celebrará su Capital Markets Day para presentar el…
Spanish 55.7 KB
2025-03-25 18:09
M&A Activity
Faes Farma S.A. ha suscrito un contrato para la adquisición de Laboratorios Edo…
Spanish 67.7 KB
2025-02-28 07:55
Investor Presentation
Informe de negocio y resultados 2024
Spanish 1.2 MB
2025-02-28 07:52
Major Shareholding Notification
La sociedad remite el Informe Anual de Gobierno Corporativo del ejercicio 2024
Spanish 426.0 KB
2025-02-28 07:51
Remuneration Information
La Sociedad remite el Informe Anual sobre remuneraciones de los consejeros del …
Spanish 213.3 KB
2025-02-28 00:00
Annual / Quarterly Financial Statement
Spanish 12.1 MB

Automate Your Workflow. Get a real-time feed of all Faes Farma S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Faes Farma S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
DEVA HOLDİNG A.Ş. Logo
Global manufacturer of human/veterinary pharmaceuticals, APIs, and medical ampoules.
Spain DEVA
Devyser Diagnostics Logo
Develops & sells genetic DNA test kits for labs in oncology, transplant & reproductive health.
Sweden DVYSR
Diamyd Medical AB (publ) Logo
Developing precision immunotherapies to preserve insulin in autoimmune diabetes.
Sweden DMYD
Diasorin Logo
Develops immunodiagnostic and molecular diagnostic kits and systems for healthcare and research.
Italy DIA
Dottikon ES Holding AG Logo
Exclusive synthesis of APIs & fine chemicals via hazardous reactions for pharma/biotech industries.
Switzerland DESN
Double Bond Pharmaceutical International AB Logo
Redeveloping drugs with proprietary delivery tech for oncology & infectious diseases.
Sweden DBP B
D.Western Therapeutics Institute, Inc. Logo Japan 4576
ECO ANIMAL HEALTH GROUP PLC Logo
Develops pharmaceuticals for respiratory & enteric diseases in global swine and poultry markets.
United Kingdom EAH
Eevia Health Plc Logo
B2B supplier of sustainable, scientifically validated extracts from Nordic plants for health brands.
Finland EEVIA
Egetis Therapeutics Logo
Develops and commercializes late-stage therapies for rare orphan diseases.
Sweden EGTX